RNAi pathways in parasitic protists and worms

J Proteomics. 2011 Aug 24;74(9):1504-14. doi: 10.1016/j.jprot.2011.02.032. Epub 2011 Mar 6.

Abstract

Tropical diseases caused by parasitic worms and protists are of major public health concern affecting millions of people worldwide. New therapeutic and diagnostic tools would be of great help in dealing with the public health and economic impact of these diseases. RNA interference (RNAi) pathways utilize small non-coding RNAs to regulate gene expression in a sequence-specific manner. In recent years, a wealth of data about the mechanisms and biological functions of RNAi pathways in distinct groups of eukaryotes has been described. Often, RNAi pathways have unique features that are restricted to groups of eukaryotes. The focus of this review will be on RNAi pathways in specific groups of parasitic eukaryotes that include Trypanosoma cruzi, Plasmodium and Schistosoma mansoni. These parasites are the causative agents of Chagas disease, Malaria, and Schistosomiasis, respectively, all of which are tropical diseases that would greatly benefit from the development of new diagnostic and therapeutic tools. In this context, we will describe specific features of RNAi pathways in each of these parasitic eukaryotic groups and discuss how they could be exploited for the treatment of tropical diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Euglenozoa
  • Helminths
  • Humans
  • Parasites / drug effects
  • Parasites / genetics*
  • Parasitic Diseases / therapy
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism*

Substances

  • RNA, Small Interfering